Brevan Howard Capital Management »

Cytokinetics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 101k 63.54
2025-09-30 $548k 10k 54.96
2024-12-31 $422k 9.0k 47.04
2024-03-31 $1.1M 15k 70.11
2023-12-31 $673k 8.1k 83.49

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
First Tr Exchange Traded Sm Cap Buywrite (FTKI)
Pdd Holdings Sponsored Ads Call Option (PDD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores Call Option (WMT)
Select Sector Spdr Tr State Street Uti Call Option (XLU)

View all positions for Brevan Howard Capital Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Integral Health Asset Management
Woodline Partners
Citadel Advisors

View all funds holding Cytokinetics